PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 2, 2013BMC Musculoskeletal Disorders54 citationsOpen Access

Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis

MAMaria AnderssonBSBjörn SvenssonIPIngemar F. Petersson

Key Points

Key points are not available for this paper at this time.

Abstract

Increasing serum-COMP levels between diagnosis and the subsequent 3 months in patients with early RA represents a novel indicator of an activated destructive process in the joint and is a promising tool to identify patients with significant joint damage progression during a 5-year period.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Andersson et al. (2013) studied this question.

synapsesocial.com/papers/69d73e9bc74376700bf31015https://doi.org/10.1186/1471-2474-14-229
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis1988 · 19,987 citations
  2. 2RELATIONSHIP BETWEEN SERUM CARTILAGE OLIGOMERIC MATRIX PROTEIN LEVELS AND DISEASE PROGRESSION IN OSTEOARTHRITIS OF THE KNEE JOINT1995 · 206 citations
  3. 3Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: A one year prospective study1998 · 104 citations
  4. 4Prognostic laboratory markers of joint damage in rheumatoid arthritis2004 · 386 citations
  5. 5Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept2003 · 82 citations